A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Rheumatoid Arthritis
Latest Information Update: 04 Nov 2021
At a glance
- Drugs ART I02 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors MeiraGTx Netherlands
- 13 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 28 Feb 2018 New trial record